Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in cervical screening technology.

M H Stoler1

  • 1Department of Pathology, University of Virginia Health System, Charlottesville, USA.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|April 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bronchoalveolar neutrophils, interferon gamma-inducible protein 10 and interleukin-7 in AIDS-associated tuberculosis.

Clinical and experimental immunology·2007
Same author

Pediatric angiosarcoma of the heart: a unique presentation and metastatic pattern.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2002
Same author

CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.

The Journal of experimental medicine·2001
Same author

Vulvar melanoma: a retrospective analysis and literature review.

Gynecologic oncology·2001
Same author

The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells.

Growth factors (Chur, Switzerland)·2001
Same author

HPV for cervical cancer screening: is the era of the molecular pap smear upon us?

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society·2001
Same journal

Chromoanagenesis in Myelodysplastic Syndromes Is Associated With Highly Complex Karyotype, TP53 Disruption and Dismal Prognosis.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same journal

Co-Existent Endometrial and Fallopian Tube Carcinoma, Molecular and Pathological Features for Risk Stratification.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same journal

RUNX2 Rearrangement as a Recurrent Molecular Event and Diagnostic Marker in Salivary Gland Keratocystoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same journal

Clinicopathological, Molecular and DNA Methylation Analysis of Ossifying Fibromyxoid Tumors Delineates the ZC3H7B::BCOR Subset as a Distinct Entity.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same journal

Baseline Tumor Proliferation and Ki-67 Are Associated With Pathologic Response to Neoadjuvant Chemoimmunotherapy in NSCLC.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same journal

Pulmonary Neuroendocrine Tumor Artificial Intelligence-Assisted Prediction of Postoperative Recurrence from Tumor Biopsy Specimens.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
See all related articles

The conventional Pap smear is a successful cervical cancer screening tool. However, new technologies like HPV testing and vaccines are challenging its role as the standard of care.

Area of Science:

  • Gynecologic Oncology
  • Cytopathology
  • Public Health

Background:

  • The conventional Pap smear has been a cornerstone of cervical cancer screening for decades.
  • Recent technological advancements prompt a re-evaluation of its status as the standard of care.

Purpose of the Study:

  • To analyze the evolving landscape of cervical cancer screening in light of new technologies.
  • To discuss the integration of cost-effectiveness and technological innovation in cervical cytopathology.

Main Methods:

  • Review of current literature on cervical cancer screening technologies.
  • Analysis of advancements in thin layer preparations, cytology automation, and human papillomavirus (HPV) testing.
  • Discussion of the impact of HPV vaccines on screening strategies.

Related Experiment Videos

Main Results:

  • New technologies, including HPV screening and vaccines, offer alternative and potentially improved methods for cervical cancer detection.
  • The field of cervical cytopathology is significantly influenced by market forces and external factors impacting clinical decision-making.

Conclusions:

  • The traditional Pap smear's role as the sole standard of care is being questioned due to technological progress.
  • A comprehensive approach integrating new diagnostics and therapeutics is essential for optimizing cervical cancer prevention strategies.